Citations (49)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Chenxi Wang, Chenxi Yu, Hongkai Chang, Jiaqi Song, Shuai Zhang, Jianguo Zhao, Jiyan Wang, Tao Wang, Qi Qi & Changliang Shan. (2023) Glucose-6-phosphate dehydrogenase: a therapeutic target for ovarian cancer. Expert Opinion on Therapeutic Targets 27:8, pages 733-743.
Read now
Read now
Shazwin Hani Shahruzaman, Sharida Fakurazi & Sandra Maniam. (2018) Targeting energy metabolism to eliminate cancer cells. Cancer Management and Research 10, pages 2325-2335.
Read now
Read now
Alihossein Saberi, Daryoush Shahbazi-Gahrouei, Mahdi Abbasian, Mehrafarin Fesharaki, Azam Baharlouei & Zahra Arab-Bafrani. (2017) Gold nanoparticles in combination with megavoltage radiation energy increased radiosensitization and apoptosis in colon cancer HT-29 cells. International Journal of Radiation Biology 93:3, pages 315-323.
Read now
Read now
Yi Zhang & Jin-Ming Yang. (2013) Altered energy metabolism in cancer. Cancer Biology & Therapy 14:2, pages 81-89.
Read now
Read now
Pradeep Kumar Sharma & Rajeev Varshney. (2012) 2-Deoxy-D-glucose and 6-aminonicotinamide-mediated Nrf2 down regulation leads to radiosensitization of malignant cells via abrogation of GSH-mediated defense. Free Radical Research 46:12, pages 1446-1457.
Read now
Read now
Mohammad Athar, Nabo K. Chaudhury, Mohammad E. Hussain & Rajeev Varshney. (2010) Hoechst 33342 induces radiosensitization in malignant glioma cells via increase in mitochondrial reactive oxygen species. Free Radical Research 44:8, pages 936-949.
Read now
Read now
Articles from other publishers (43)
Alfar Ahamed, Rendy Hosea, Shourong Wu & Vivi Kasim. (2023) The Emerging Roles of the Metabolic Regulator G6PD in Human Cancers. International Journal of Molecular Sciences 24:24, pages 17238.
Crossref
Crossref
Hyunkoo Kang, Byeongsoo Kim, Junhyeong Park, HyeSook Youn & BuHyun Youn. (2023) The Warburg effect on radioresistance: Survival beyond growth. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1878:6, pages 188988.
Crossref
Crossref
Peijie Zheng, Chuntao Zhou, Liuyi Lu, Bin Liu & Yuemin Ding. (2022) Elesclomol: a copper ionophore targeting mitochondrial metabolism for cancer therapy. Journal of Experimental & Clinical Cancer Research 41:1.
Crossref
Crossref
Joanna Kubik, Ewelina Humeniuk, Grzegorz Adamczuk, Barbara Madej-Czerwonka & Agnieszka Korga-Plewko. (2022) Targeting Energy Metabolism in Cancer Treatment. International Journal of Molecular Sciences 23:10, pages 5572.
Crossref
Crossref
Jiaqi Song, Huanran Sun, Shuai Zhang & Changliang Shan. (2022) The Multiple Roles of Glucose-6-Phosphate Dehydrogenase in Tumorigenesis and Cancer Chemoresistance. Life 12:2, pages 271.
Crossref
Crossref
Huakan Zhao & Yongsheng Li. (2021) Cancer metabolism and intervention therapy. Molecular Biomedicine 2:1.
Crossref
Crossref
Seema Gupta & Bilikere S. Dwarakanath. (2020) Modulation of Immuno-biome during Radio-sensitization of Tumors by Glycolytic Inhibitors. Current Medicinal Chemistry 27:24, pages 4002-4015.
Crossref
Crossref
John M. Floberg & Julie K. Schwarz. (2019) Manipulation of Glucose and Hydroperoxide Metabolism to Improve Radiation Response. Seminars in Radiation Oncology 29:1, pages 33-41.
Crossref
Crossref
Gang Wang, Jun‐Jie Wang, Pei‐Hao Yin, Ke Xu, Yu‐Zhu Wang, Feng Shi, Jing Gao & Xing‐Li Fu. (2018) New strategies for targeting glucose metabolism–mediated acidosis for colorectal cancer therapy. Journal of Cellular Physiology 234:1, pages 348-368.
Crossref
Crossref
Mark D. Wilkie, Andrew S. Lau, Nikolina Vlatkovic, Terence M. Jones & Mark T. Boyd. (2018) Metabolic signature of squamous cell carcinoma of the head and neck: Consequences of TP53 mutation and therapeutic perspectives. Oral Oncology 83, pages 1-10.
Crossref
Crossref
Young-Suk Jung, Abdo J. Najy, Wei Huang, Seema Sethi, Michael Snyder, Wael Sakr, Gregory Dyson, Maik Hüttemann, Icksoo Lee, Rouba Ali-Fehmi, Silvia Franceschi, Linda Struijk, Harold E. Kim, Ikuko Kato & Hyeong-Reh Choi Kim. (2017) HPV-associated differential regulation of tumor metabolism in oropharyngeal head and neck cancer. Oncotarget 8:31, pages 51530-51541.
Crossref
Crossref
Kehua Jin, Li Li, Xihuan Sun, Qingyan Xu, Siyang Song, Yuemao Shen & Xianming Deng. (2017) Mycoepoxydiene suppresses HeLa cell growth by inhibiting glycolysis and the pentose phosphate pathway. Applied Microbiology and Biotechnology 101:10, pages 4201-4213.
Crossref
Crossref
Seema Gupta, Amrita Roy & Bilikere S. Dwarakanath. (2017) Metabolic Cooperation and Competition in the Tumor Microenvironment: Implications for Therapy. Frontiers in Oncology 7.
Crossref
Crossref
Sergio Rey, Luana Schito, Marianne Koritzinsky & Bradly G. Wouters. (2017) Molecular targeting of hypoxia in radiotherapy. Advanced Drug Delivery Reviews 109, pages 45-62.
Crossref
Crossref
Christoph Herbel, Nikolaos Patsoukis, Kankana Bardhan, Pankaj Seth, Jessica D. Weaver & Vassiliki A. Boussiotis. (2016) Clinical significance of T cell metabolic reprogramming in cancer. Clinical and Translational Medicine 5:1.
Crossref
Crossref
Derek A. Franklin, Yizhou He, Patrick L. Leslie, Andrey P. Tikunov, Nick Fenger, Jeffrey M. Macdonald & Yanping Zhang. (2016) p53 coordinates DNA repair with nucleotide synthesis by suppressing PFKFB3 expression and promoting the pentose phosphate pathway. Scientific Reports 6:1.
Crossref
Crossref
Jonathan E. Schoenhals, Steven N. Seyedin, Chad Tang, Maria A. Cortez, Sharareh Niknam, Efrosini Tsouko, Joe Y. Chang, Stephen M. Hahn & James W. Welsh. (2016) Preclinical Rationale and Clinical Considerations for Radiotherapy Plus Immunotherapy. The Cancer Journal 22:2, pages 130-137.
Crossref
Crossref
AH Kesarwala, MC Krishna & JB Mitchell. (2016) Oxidative stress in oral diseases. Oral Diseases 22:1, pages 9-18.
Crossref
Crossref
Jing Lv, Jieqiong Wang, Siyu Chang, Mingyao Liu & Xiufeng Pang. (2016) The greedy nature of mutant RAS: a boon for drug discovery targeting cancer metabolism?. Acta Biochimica et Biophysica Sinica 48:1, pages 17-26.
Crossref
Crossref
A. Sundaresan, K. Marriott, J. Mao, S. Bhuiyan & P. Denkins. (2015) The Effects of Benzofuran-2-Carboxylic Acid Derivatives as Countermeasures in Immune Modulation and Cancer Cell Inhibition. Microgravity Science and Technology 27:3, pages 129-140.
Crossref
Crossref
Nada Al Hasawi, Mariam F. Alkandari & Yunus A. Luqmani. (2014) Phosphofructokinase: A mediator of glycolytic flux in cancer progression. Critical Reviews in Oncology/Hematology 92:3, pages 312-321.
Crossref
Crossref
Sandra Kuntz, Sabine Mazerbourg, Michel Boisbrun, Claudia Cerella, Marc Diederich, Isabelle Grillier-Vuissoz & Stephane Flament. (2014) Energy restriction mimetic agents to target cancer cells: Comparison between 2-deoxyglucose and thiazolidinediones. Biochemical Pharmacology 92:1, pages 102-111.
Crossref
Crossref
Peng Jiang, Wenjing Du & Mian Wu. (2014) Regulation of the pentose phosphate pathway in cancer. Protein & Cell 5:8, pages 592-602.
Crossref
Crossref
Pierre Danhier, Christophe J. De Saedeleer, Oussama Karroum, Géraldine De Preter, Paolo E. Porporato, Bénédicte F. Jordan, Bernard Gallez & Pierre Sonveaux. (2013) Optimization of Tumor Radiotherapy With Modulators of Cell Metabolism: Toward Clinical Applications. Seminars in Radiation Oncology 23:4, pages 262-272.
Crossref
Crossref
Mohita Upadhyay, Jasmine Samal, Manish Kandpal, Om Vir Singh & Perumal Vivekanandan. (2013) The Warburg effect: Insights from the past decade. Pharmacology & Therapeutics 137:3, pages 318-330.
Crossref
Crossref
Pradeep Kumar Sharma, Bilikere Srinivasa Dwarakanath & Rajeev Varshney. (2012) Radiosensitization by 2-deoxy-D-glucose and 6-aminonicotinamide involves activation of redox sensitive ASK1-JNK/p38MAPK signaling in head and neck cancer cells. Free Radical Biology and Medicine 53:7, pages 1500-1513.
Crossref
Crossref
Chiara Riganti, Elena Gazzano, Manuela Polimeni, Elisabetta Aldieri & Dario Ghigo. (2012) The pentose phosphate pathway: An antioxidant defense and a crossroad in tumor cell fate. Free Radical Biology and Medicine 53:3, pages 421-436.
Crossref
Crossref
Richa Bhardwaj, Pradeep K. Sharma, S. P. S. Jadon & Rajeev Varshney. (2012) A combination of 2-deoxy-d-glucose and 6-aminonicotinamide induces cell cycle arrest and apoptosis selectively in irradiated human malignant cells. Tumor Biology 33:4, pages 1021-1030.
Crossref
Crossref
Vlad C. Sandulache & Jeffrey N. Myers. (2011) Altered metabolism in head and neck squamous cell carcinoma: an opportunity for identification of novel biomarkers and drug targets. Head & Neck 34:2, pages 282-290.
Crossref
Crossref
Brijesh M. Madhok, Sashidhar Yeluri, Sarah L. Perry, Thomas A. Hughes & David G. Jayne. (2011) Targeting Glucose Metabolism. American Journal of Clinical Oncology 34:6, pages 628-635.
Crossref
Crossref
Richa Bhardwaj, Pradeep Kumar Sharma, Suryaprakash Singh Jadon & Rajeev Varshney. (2011) A combination of 2-deoxy-d-glucose and 6-aminonicotinamide induces oxidative stress mediated selective radiosensitization of malignant cells via mitochondrial dysfunction. Tumor Biology 32:5, pages 951-964.
Crossref
Crossref
Hiroshi Hoshikawa, Kanako Indo, Terushige Mori & Nozomu Mori. (2011) Enhancement of the radiation effects by d-allose in head and neck cancer cells. Cancer Letters 306:1, pages 60-66.
Crossref
Crossref
Pradeep K. Sharma, Richa Bhardwaj, Bilikere S. Dwarakanath & Rajeev Varshney. (2010) Metabolic oxidative stress induced by a combination of 2-DG and 6-AN enhances radiation damage selectively in malignant cells via non-coordinated expression of antioxidant enzymes. Cancer Letters 295:2, pages 154-166.
Crossref
Crossref
José M. Cuezva, Álvaro D. Ortega, Imke Willers, Laura Sánchez-Cenizo, Marcos Aldea & María Sánchez-Aragó. (2009) The tumor suppressor function of mitochondria: Translation into the clinics. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1792:12, pages 1145-1158.
Crossref
Crossref
BS DwarakanathViney Jain. (2009)
Targeting glucose metabolism with 2-deoxy-
D
-glucose for improving cancer therapy
. Future Oncology 5:5, pages 581-585.
Crossref
Crossref
Regan M. Memmott & Phillip A. Dennis. (2009) Akt-dependent and -independent mechanisms of mTOR regulation in cancer. Cellular Signalling 21:5, pages 656-664.
Crossref
Crossref
Nicholas C. Denko. (2008) Hypoxia, HIF1 and glucose metabolism in the solid tumour. Nature Reviews Cancer 8:9, pages 705-713.
Crossref
Crossref
Emma Hernlund, Linda Strandberg Ihrlund, Omar Khan, Yildiz Ozlem Ates, Stig Linder, Theocharis Panaretakis & Maria C. Shoshan. (2008) Potentiation of chemotherapeutic drugs by energy metabolism inhibitors 2-deoxyglucose and etomoxir. International Journal of Cancer 123:2, pages 476-483.
Crossref
Crossref
Sigrun Langbein, Wilma M. Frederiks, Axel zur Hausen, Juljane Popa, Jan Lehmann, Christel Weiss, Peter Alken & Johannes F. Coy. (2008) Metastasis is promoted by a bioenergetic switch: New targets for progressive renal cell cancer. International Journal of Cancer 122:11, pages 2422-2428.
Crossref
Crossref
Diansheng Zhong, Xiuju Liu, Katherine Schafer-Hales, Adam I. Marcus, Fadlo R. Khuri, Shi-Yong Sun & Wei Zhou. (2008) 2-Deoxyglucose induces Akt phosphorylation via a mechanism independent of LKB1/AMP-activated protein kinase signaling activation or glycolysis inhibition. Molecular Cancer Therapeutics 7:4, pages 809-817.
Crossref
Crossref
Robert A. Gatenby & Robert J. Gillies. (2007) Glycolysis in cancer: A potential target for therapy. The International Journal of Biochemistry & Cell Biology 39:7-8, pages 1358-1366.
Crossref
Crossref
H Pelicano, D S Martin, R-H Xu & P Huang. (2006) Glycolysis inhibition for anticancer treatment. Oncogene 25:34, pages 4633-4646.
Crossref
Crossref
Anissa Belkaid, Ian B. Copland, Duna Massillon & Borhane Annabi. (2006) Silencing of the human microsomal glucose-6-phosphate translocase induces glioma cell death: Potential new anticancer target for curcumin. FEBS Letters 580:15, pages 3746-3752.
Crossref
Crossref